1. Home
  2. ICCC vs DTIL Comparison

ICCC vs DTIL Comparison

Compare ICCC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$5.90

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$4.99

Market Cap

123.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
DTIL
Founded
1982
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
123.0M
IPO Year
1987
2019

Fundamental Metrics

Financial Performance
Metric
ICCC
DTIL
Price
$5.90
$4.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$47.00
AVG Volume (30 Days)
20.2K
197.8K
Earning Date
11-13-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$27,769,304.00
$698,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$34.30
P/E Ratio
$21.57
N/A
Revenue Growth
16.49
N/A
52 Week Low
$4.28
$3.61
52 Week High
$7.60
$8.82

Technical Indicators

Market Signals
Indicator
ICCC
DTIL
Relative Strength Index (RSI) 61.03 41.21
Support Level $4.72 $4.61
Resistance Level $5.36 $5.09
Average True Range (ATR) 0.31 0.33
MACD 0.16 0.02
Stochastic Oscillator 98.04 33.51

Price Performance

Historical Comparison
ICCC
DTIL

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Share on Social Networks: